Accelmed Partners is a US based private equity firm that invests in both small and mid-cap private and public companies. The fund selectively invests in Revenue stage US HealthTech companies. The firm deploys a dual strategy of: (1) Buyout/platform targeting mature companies with significant revenue base but lacking new product and growth, by addition of innovative medical technologies, mainly developed in Israel; and a (2) Growth strategy focused in companies with innovative products, >$10M LTM revenues, proven market traction, strong double-digit growth and within 2-4 years of a liquidity event.
Balanced
1 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.